Over-expression of the Endocan gene in endothelial cells from hepatocellular carcinoma is associated with angiogenesis and tumour invasion

Journal of International Medical Research

Volumn 38, Issue 2, 2010, Pages 498-510

  Chen, L Y ^a   Liu, X ^a   Wang, S L ^a   Qin, C Y ^a  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

Author keywords

Angiogenesis; Endocan; Endothelial cells; Hepatocellular carcinoma; VEGF

Indexed keywords

ALPHA FETOPROTEIN; BIOLOGICAL MARKER; ENDOCAN; MESSENGER RNA; PROTEOGLYCAN; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER INVASION; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MALE; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR DIFFERENTIATION; TUMOR VASCULARIZATION; WESTERN BLOTTING;

EID: 77953728436     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323001003800213     Document Type: Article

References (36)

1. Parkin DM, Bray F, Ferlay J, et al:. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108.
2. El-Serag HB, Davila JA, Petersen NJ, et al: The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann Int Med 2003; 139: 817-823.
3. Parkin DM: Global cancer statistics in the year 2000. Lancet Oncol 2001; 2: 533-543.
4. Tang ZY: Hepatocellular carcinoma-cause, treatment and metastasis. World J Castroenterol 2001; 7: 445-454.
5. Ozaki I, Mizuta T, Zhao G, et al:. Involvement of the Ets-1 gene in overexpression of matrilysin in human hepatocellular carcinoma. Cancer Res 2000; 60: 6519-6525.
6. Llovet JM, Burroughs A, Bruix J: Hepatocellular carcinoma. Lancet 2003; 362: 1907-1917.
7. Carmeliet P: Mechanisms of angiogenesis and arteriogenesis. Nat Med 2000; 6: 389-395.
8. Park YN, Kim YB, Yang KM et al:. Increased expression of vascular endothelial growth factor and angiogenesis in the early stage of multistep hepatocarcinogenesis. Arch Pathol Lab Med 2000; 124: 1061-1065.
9. St Croix B, Rago C, Velculescu V, et al:. Genes expressed in human tumor endothelium. Science 2000; 289: 1197-1202.
10. Oh P, Li Y, Yu I, et al. Subtractive proteomic mapping of the endothelial surface in lung and solid tumours for tissue-specific therapy. Nature 2004; 429: 629-635.
11. Lassalle P, Molet S, Janin A, et al:. ESM-1 is a novel human endothelial cell-specific molecule expressed in lung and regulated by cytokines. J Biol Chem 1996; 271: 20458-20464.
12. Bechard D, Meignin V, Scherpereel A, et al: Characterization of the secreted form of endothelial-cell-specific molecule 1 by specific monoclonal antibodies. J Vase Res 2000; 37: 417-425.
13. Hendrix MJ, Seftor EA, Hess AR, et al:. Molecular plasticity of human melanoma cells. Oncogene 2003; 22: 3070-3075.
14. Van't Veer LJ, Dai H, van de Vijver MJ, et al:. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002; 415: 530-536.
15. Amatschek S, Koenig U, Auer H, et al. Tissue-wide expression profiling using cDNA subtraction and microarrays to identify tumor-specific genes. Cancer Res 2004; 64: 844-856.
16. Lenburg M, Liou L, Gerry N, et al: Previously unidentified changes in renal cell carcinoma gene expression identified by parametric analysis of microarray data. BMC Cancer 2003; 3:31.
17. Borczuk AC, Shah L, Pearson GD, et al:. Molecular signatures in biopsy specimens of lung cancer. Am J Resplr Crit Care Med 2004; 170: 167-174.
18. Rennel E, Mellberg S, Dimberg A, et al. Endocan is a VEGF-A and PI3K regulated gene with increased expression in human renal cancer. Exp Cell Res 2007; 313: 1285-1294.
19. Zhang T, Sun H-C, Xu Y, et al. Overexpression of platelet-derived growth factor receptor alpha in endothelial cells of hepatocellular carcinoma associated with high metastatic potential. Clin Cancer Res 2005; 11: 8557-8563.
20. Benetti A, Berenzi A, Gambarotti M, et al. Transforming growth factor-JJl and CD105 promote the migration of hepatocellular carcinoma-derived endothelium. Cancer Res 2008; 68: 8626-8634.
21. Du XL, Jiang T, Zhao WB, et al. Gene alterations in tumor-associated endothelial cell from endometrial cancer. Int J Mol Med 2008; 22: 619-632.
22. Carmeliet P, Jain RK: Angiogenesis in cancer and other diseases. Nature 2000; 407: 249-257.
23. Sarrazin S, Adam E, Lyon M, et al:. Endocan or endothelial cell specific molecule-1 (ESM-1): a potential novel endothelial cell marker and a new target for cancer therapy. Blochlm Blophys Acta 2006; 1765:25-37.
24. Huang GW, Tao YM, Ding X: Endocan expression correlated with poor survival in human hepatocellular carcinoma. Dig Dis Sci 2009; 54: 389-394.
25. Ijichi M, Takayama T, Matsumura M, et al:. α-Fetoprotein mRNA in the circulation as a predictor of postsurgical recurrence of hepatocellular carcinoma: a prospective study. Hepatology 2002; 35: 853-860.
26. Poon RT, Fan ST, Wong J: Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg 2000; 232: 10-24.
27. Nzeako UC, Goodman ZD, Ishak KG: Hepatocellular carcinoma in cirrhotic and noncirrhotic livers-a clinico-histopathologic study of 804 North American patients. Am J Clin Pathol 1996; 105: 65-75.
28. Okuda K, Nakashima T, Kojiro M, et al. Hepatocellular carcinoma without cirrhosis in Japanese patients. Castroenterology 1989; 97: 140-146.
29. Zhang ZL, Liu ZS, Sun Q: Expression of angiopoietins, Tie2 and vascular endothelial growth factor in angiogenesis and progression of hepatocellular carcinoma. World J Castroenterol 2006; 12: 4241-4245.
30. Abid MR, Yi X, Yano K, et al:. Vascular endocan is preferentially expressed in tumor endothelium. Microvasc Res 2006; 72: 136-145.
31. Scherpereel A, Gentina T, Grigoriu B, et al:. Overexpression of endocan induces tumor formation. Cancer Res 2003; 63: 6084-6089.
32. Grigoriu BD, Depontieu F, Scherpereel A, et al:. Endocan expression and relationship with survival in human non-small cell lung cancer. Clin Cancer Res 2006; 12: 4575-4582.
33. Gerritsen ME, Tomlinson JE, Zlot C, et al:. Using gene expression profiling to identify the molecular basis of the synergistic actions of hepatocyte growth factor and vascular endothelial growth factor in human endothelial cells. Br J Pharmacol 2003; 140: 595-610.
34. Aitkenhead M, Wang S-J, Nakatsu MN, et al:. Identification of endothelial cell genes expressed in an in vitro model of angiogenesis: induction of ESM-1, βg-h3, and NrCAM. Microvasc Res 2002; 63: 159-171.
35. Bechard D, Gentina T, Delehedde M, et al. Endocan is a novel chondroitin sulfate/dermatan sulfate proteoglycan that promotes hepatocyte growth factor/scatter factor mitogenic activity. J Biol Chem 2001; 276: 48341-48349.
36. Bechard D, Scherpereel A, Hammad H, et al:. Human endothelial-cell specific molecule-1 binds directly to the integrin CDlla/CD18 (LFA-1) and blocks binding to intercellular adhesion molecule-1. J Immunol 2001; 167: 3099-3106.